tiprankstipranks
Trending News
More News >
Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
US Market

Olema Pharmaceuticals (OLMA) Income Statement

Compare
705 Followers

Olema Pharmaceuticals Income Statement

Last quarter (Q4 2024), Olema Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Olema Pharmaceuticals's net income was $-33.57M. See Olema Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -377.00K$ -1.66M$ -1.66M$ -11.00K
Operating Expenses
$ 142.26M$ 104.96M$ 106.99M$ 71.49M$ 21.53M
Depreciation and Amortization
$ 0.00$ 377.00K$ 1.66M$ 1.66M$ 11.00K
EBITDA
$ -142.26M$ -104.58M$ -103.13M$ -69.43M$ -21.52M
Operating Income
$ -142.26M$ -104.96M$ -106.99M$ -71.49M$ -21.53M
Other Income/Expenses
$ 12.78M$ 8.31M$ 2.20M$ 395.00K$ -593.00K
Pretax Income
$ -129.47M$ -96.66M$ -104.79M$ -71.10M$ -22.12M
Net Income
$ -129.47M$ -96.66M$ -102.59M$ -70.89M$ -22.76M
Per Share Metrics
Basic EPS
$ -2.20$ -2.14$ -2.56$ -1.79$ -0.58
Diluted EPS
$ -2.20$ -2.14$ -2.56$ -1.79$ -0.58
Weighted Average Shares Outstanding
58.74M 45.25M 40.00M 39.52M 39.31M
Weighted Average Shares Outstanding (Diluted)
58.74M 45.25M 40.00M 39.52M 39.31M
Currency in USD

Olema Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis